Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JWK001 in Neovascular Age-Related Macular Degeneration
NCT07776522Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of JWK001 in neovascular age-related macular degeneration (NVAMD), sponsored by West China Hospital of Sichuan University. Started Aug 2026; status: recruiting.
02
Drugs
JWK001
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT07776522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776522.